2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查

2019-11-18 加拿大预防保健工作组 CMAJ. 2019 Nov 18;191(46):E1274-E1280.

2019年11月,加拿大预防保健工作组(CTFPHC)发布了基层医疗中成人无症状甲状腺功能不全的筛查建议,文章主要为基层医疗卫生保健人员在成人无症状甲状腺功能不全的筛查方面提供指导建议。

中文标题:

2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查

英文标题:

Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care.

发布日期:

2019-11-18

简要介绍:

2019年11月,加拿大预防保健工作组(CTFPHC)发布了基层医疗中成人无症状甲状腺功能不全的筛查建议,文章主要为基层医疗卫生保健人员在成人无症状甲状腺功能不全的筛查方面提供指导建议。

 

拓展指南:甲状腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查)] GetToolGuiderByIdResponse(projectId=1, id=e5a141c0018330c5, title=2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查, enTitle=Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care., guiderFrom=CMAJ. 2019 Nov 18;191(46):E1274-E1280., authorId=null, author=, summary=2019年11月,加拿大预防保健工作组(CTFPHC)发布了基层医疗中成人无症状甲状腺功能不全的筛查建议,文章主要为基层医疗卫生保健人员在成人无症状甲状腺功能不全的筛查方面提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=725, associationName=加拿大预防保健工作组, associationIntro=加拿大预防保健工作组(CTFPHC), 成立于1976年9月,每年定期召开三次预防保健会议。 CTFPHC是加拿大公共卫生署成立的一个独立机构,包括14个初级保健和预防领域的专家。, copyright=0, guiderPublishedTime=Mon Nov 18 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年11月,加拿大预防保健工作组(CTFPHC)发布了基层医疗中成人无症状甲状腺功能不全的筛查建议,文章主要为基层医疗卫生保健人员在成人无症状甲状腺功能不全的筛查方面提供指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>甲状腺</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=8f5dc1c001823621" title="分化型甲状腺癌术后 131 I治疗前评估专家共识" target=_blank>分化型甲状腺癌术后 131 I治疗前评估专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=3514d1c0018103a0" title="甲状腺微小乳头状癌热消融诊疗指征专家共识" target=_blank>甲状腺微小乳头状癌热消融诊疗指征专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d13ad1c001e9935a" title="2019 ESMO临床实践指南:甲状腺癌的诊断,治疗和随访" target=_blank>2019 ESMO临床实践指南:甲状腺癌的诊断,治疗和随访</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=96b171c001e976ed" title="NCCN临床实践指南:甲状腺癌(2019.V2)" target=_blank>NCCN临床实践指南:甲状腺癌(2019.V2)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f74381c001e9a492" title="妊娠和产后甲状腺疾病诊治指南(第2版)" target=_blank>妊娠和产后甲状腺疾病诊治指南(第2版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA" target=_blank>有关甲状腺更多指南</a></ul>, tagList=[TagDto(tagId=1900, tagName=基层医疗), TagDto(tagId=97221, tagName=无症状甲状腺功能不全), TagDto(tagId=636, tagName=筛查)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5997, appHits=169, showAppHits=0, pcHits=2016, showPcHits=4432, likes=101, shares=3, comments=3, approvalStatus=1, publishedTime=Wed Nov 27 00:27:53 CST 2019, publishedTimeString=2019-11-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 27 00:27:53 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 05:06:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查)])
2019 CTFPHC建议:基层医疗中成人无症状甲状腺功能不全的筛查
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=898108, encodeId=d1ab89810886, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Mon Nov 09 23:05:23 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809853, encodeId=5a3080985339, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Mon Aug 17 21:06:05 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2020-11-09 ms7000001395190706

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=898108, encodeId=d1ab89810886, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Mon Nov 09 23:05:23 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809853, encodeId=5a3080985339, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Mon Aug 17 21:06:05 CST 2020, time=2020-08-17, status=1, ipAttribution=)]
    2020-08-17 ms5000002046462755

    0